University of Alberta, Edmonton, AB, Canada.
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231194974. doi: 10.1177/21501319231194974.
INTRODUCTION/OBJECTIVES: Some rheumatology patients use or contemplate using cannabis, however, may not be transparent about use with their providers. The objective of this qualitative descriptive study was to describe beliefs, perceptions, and learning needs of adults with rheumatic conditions regarding the use of cannabis products.
Purposive sampling was conducted through a rheumatology clinic and sought participants who were using or thinking about using cannabis. Two online focus groups based on cannabis use patterns (non-users and users) were conducted separately. Interviews were audio recorded and transcribed. Three research team members read the transcripts independently to identify initial codes and themes. Data saturation was reached with the interviews.
We recruited 12 participants between 52 and 85 years old. The first theme was pain and desperation. Stigma was the second theme with a perception of physician opposition to cannabis, and the reluctance of many participants to discuss cannabis use with physicians. The final theme was a need for information and a general lack of trustworthy and credible sources. Users were willing to try cannabis even if they still had questions.
Rheumatology patients are open to using cannabis due to the burden and suffering associated with pain. They remain silent on the topic, however, because of stigma and lack of engagement from health care professionals, particularly physicians. Patients voiced a strong need for information regarding cannabis and want healthcare providers to initiate discussion. These findings are clinically relevant to the management of rheumatic conditions and the promotion of therapeutic relationships.
简介/目的：一些风湿病患者使用或考虑使用大麻，但可能不会向其提供者透露使用情况。本定性描述性研究的目的是描述患有风湿性疾病的成年人对使用大麻产品的信念、看法和学习需求。
通过风湿病诊所进行了目的性抽样，并招募了正在使用或考虑使用大麻的参与者。根据大麻使用模式（非使用者和使用者）分别进行了两次在线焦点小组讨论。访谈进行了录音并转录。三名研究小组成员独立阅读了转录本，以确定初始代码和主题。访谈达到了数据饱和。
我们招募了 12 名年龄在 52 岁至 85 岁之间的参与者。第一个主题是疼痛和绝望。第二个主题是耻辱感，人们认为医生反对大麻，许多参与者不愿意与医生讨论大麻的使用情况。最后一个主题是对信息的需求以及普遍缺乏值得信赖的可靠信息来源。尽管仍有疑问，使用者还是愿意尝试大麻。
由于与疼痛相关的负担和痛苦，风湿病患者愿意使用大麻。然而，由于耻辱感和医疗保健专业人员（尤其是医生）的参与度低，他们对此保持沉默。患者强烈需要有关大麻的信息，并希望医疗保健提供者主动讨论这个问题。这些发现与风湿性疾病的管理和促进治疗关系具有临床相关性。
